Journal of Contemporary Brachytherapy

Comprehensive clinical dosimetry in contact skin interventional radiotherapy (modern brachytherapy): Practical tips and tricks

Bruno Fionda 1
,
Enrico Rosa 2, 3
,
Elisa Placidi 2
,
Valentina Lancellotta 1
,
Pierpaolo Dragonetti 1
,
Maria Concetta La Milia 1
,
Martina De Angeli 1
,
Francesco Pastore 4
,
Mariangela Massaccesi 4
,
Piotr Wojcieszek 5
,
Frank-André Siebert 6
,
Maria Antonietta Gambacorta 4, 7
,
Marco De Spirito 2, 7
,
Luca Tagliaferri 1, 7

  1. UOC Degenze di Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

  2. UOC Fisica per le Scienze della Vita, Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

  3. eCampus University, Novedrate (CO), Italy

  4. UOC Servizio di Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

  5. Brachytherapy Department, Maria Skłodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland

  6. Clinic of Radiotherapy, University Hospital of Schleswig-Holstein, Campus Kiel, Germany

  7. Università Cattolica del Sacro Cuore, Rome, Italy

J Contemp Brachytherapy 2026

DOI: https://doi.org/10.5114/jcb.2026.164560
Data publikacji online: 2026/09/08
Article file
Comprehensive clinical dosimetry.pdf
  1. Lee CT, Lehrer EJ, Aphale A et al. Surgical excision, Mohs micrographic surgery, external-beam radiotherapy, or brachytherapy for indolent skin cancer: An international meta-analysis of 58 studies with 21,000 patients. Cancer 2019; 125: 3582-3594.
  2. Zaorsky NG, Lee CT, Zhang E et al. Skin CanceR Brachytherapy vs External beam radiation therapy (SCRiBE) meta-analysis. Radiother Oncol 2018; 126: 386-393.
  3. Stratigos AJ, Garbe C, Dessinioti C et al. EADO, EDF, ESTRO, UEMS, EADV and EORTC. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023. Eur J Cancer 2023; 193: 113252.
  4. Peris K, Fargnoli MC, Kaufmann R et al. EADO”A, EDF”B, ESTRO”C, UEMS”D and EADV”E. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023. Eur J Cancer 2023; 192: 113254.
  5. Rembielak A, Mansy G, Barnes EA et al. Advances in skin brachytherapy: cosmesis and function preservation. Clin Oncol (R Coll Radiol) 2023; 35: 507-515.
  6. Skowronek J. Brachytherapy in the treatment of skin cancer: an overview. Postepy Dermatol Alergol 2015; 32: 362-367.
  7. Tagliaferri L, Ciardo FG, Fionda B et al. Non-melanoma skin cancer treated by contact high-dose-rate radiotherapy (brachytherapy): a mono-institutional series and literature review. In Vivo 2021; 35: 2313-2319.
  8. Alam M, Nanda S, Mittal BB et al. The use of brachytherapy in the treatment of nonmelanoma skin cancer: a review. J Am Acad Dermatol 2011; 65: 377-388.
  9. Ouhib Z, Kasper M, Perez Calatayud J et al. Aspects of dosimetry and clinical practice of skin brachytherapy: The American Brachytherapy Society working group report. Brachytherapy 2015; 14: 840-858.
  10. Major T, Fröhlich G, Ágoston P et al. The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry. Strahlenther Onkol 2022; 198: 93-109.
  11. Ota K, Adar T, Dover L et al. Review: the reemergence of brachytherapy as treatment for non-melanoma skin cancer. J Dermatolog Treat 2018; 29: 170-175.
  12. Fionda B, Placidi E, Lancellotta V et al. COMIRI – COMplexity Index of interventional Radiotherapy (brachytherapy) Implants: assessment of procedures based on type, equipment, and team. J Contemp Brachytherapy 2024; 16: 306-309.
  13. Placidi E, Fionda B, Rosa E et al. Retrospective dosimetric comparison of HDR interventional radiotherapy (brachytherapy) versus planning with VMAT and electron beam therapy for non-melanoma skin cancer treatment. Appl Sci 2024; 14: 10669.
  14. Spelman L, Christie D, Kaminski A et al. Radiotherapy, utilizing volumetric modulated arc therapy, for extensive skin field cancerization: a retrospective case series assessing efficacy, safety, and cosmetic outcomes at 12 months after treatment. Case Rep Dermatol 2022; 14: 31-38.
  15. Zablow AI, Eanelli TR, Sanfilippo LJ. Electron beam therapy for skin cancer of the head and neck. Head Neck 1992; 14: 188-195.
  16. Wojcicka JB, Lasher DE, McAfee SS et al. Dosimetric comparison of three different treatment techniques in extensive scalp lesion irradiation. Radiother Oncol 2009; 91: 255-260.
  17. Boman EL, Paterson DB, Pearson S et al. Dosimetric comparison of surface mould HDR brachytherapy with VMAT. J Med Radiat Sci 2018; 65: 311-318.
  18. Fionda B, Placidi E, Rosa E et al. Multilayer intensity modulated contact interventional radiotherapy (brachytherapy): Stretching the therapeutic window in skin cancer. J Contemp Brachytherapy 2023; 15: 220-223.
  19. Rose JN, McLaughlin PY, Hanna TP et al. Surface mold brachytherapy for nonmelanoma skin cancer: Canadian patterns of practice. Pract Radiat Oncol 2014; 4: 398-403.
  20. Likhacheva AO, Devlin PM, Shirvani SM et al. Skin surface brachytherapy: A survey of contemporary practice patterns. Brachytherapy 2017; 16: 223-229.
  21. Gonzalez-Perez V, Rembielak A, Guinot JL et al. H&N and Skin (HNS) GEC-ESTRO Working Group critical review of recommendations regarding prescription depth, bolus thickness and maximum dose in skin superficial brachytherapy with flaps and customized moulds. Radiother Oncol 2022; 175: 122-132.
  22. Guinot JL, Rembielak A, Perez-Calatayud J et al. GEC ESTRO. GEC-ESTRO ACROP recommendations in skin brachytherapy. Radiother Oncol 2018; 126: 377-385.
  23. Jaberi R, Siavashpour Z, Akha NZ et al. Validation of an individualized home-made superficial brachytherapy mold applied for deep nonmelanoma skin cancer. Rep Pract Oncol Radiother 2022; 27: 1010-1018.
  24. Brovchuk S, Park SJ, Shepil Z et al. High-dose-rate skin brachytherapy with interstitial, surface, or a combination of interstitial and surface mold technique. J Contemp Brachytherapy 2022; 14: 107-114.
  25. Rosa E, Raponi S, Fionda B et al. Impact of applicator curvature in contact interventional radiotherapy (brachytherapy) for skin cancer: exploring the “Nautilus Effect”. Phys Med 2026; 145: 105767.
  26. Wills RJ, Lowe G, Jones CL et al. Dosimetric comparison of volumetric modulated arc therapy (VMAT) and high-dose-rate brachytherapy (HDR-BT) for superficial skin irradiation with significant curvature in one or more planes. Strahlenther Onkol 2021; 197: 547-554.
  27. Sabbas AM, Kulidzhanov FG, Presser J et al. HDR brachytherapy with surface applicators: technical considerations and dosimetry. Technol Cancer Res Treat 2004; 3: 259-267.
  28. Oh M, Wang Z, Malhotra HK et al. Impact of surface curvature on dose delivery in intraoperative high-dose-rate brachytherapy. Med Dosim 2009; 34: 63-74.
  29. Beddar AS, Krishnan S, Briere TM et al. The optimization of dose delivery for intraoperative high-dose-rate radiation therapy using curved HAM applicators. Radiother Oncol 2006; 78: 207-212.
  30. Sabbas AM, Kulidzhanov FG, Presser J et al. HDR brachytherapy with surface applicators: technical considerations and dosimetry. Technol Cancer Res Treat 2004; 3: 259-267.
  31. Barnes EA, Tsao MN, Taggar AS et al. Optimizing surface mould brachytherapy for treatment of nasal basal cell carcinoma using customized applicators. Brachytherapy 2023; 22: 665-672.
  32. Kuncman Ł, Kozłowski S, Pietraszek A et al. Highly conformal CT based surface mould brachytherapy for non-melanoma skin cancers of earlobe and nose. J Contemp Brachytherapy 2016; 8: 195-200.
  33. Placidi E, Fionda B, Rosa E et al. Dosimetric impact of applying a model-based dose calculation algorithm for skin cancer brachytherapy (interventional radiotherapy). J Contemp Brachytherapy 2023; 15: 448-452.
  34. Zwierzchowski G, Bielęda G, Szymbor A et al. Personalized superficial HDR brachytherapy-dosimetric verification of dose distribution with lead shielding of critical organs in the head and neck region. J Pers Med 2022; 12: 1432.
  35. Gogineni E, Cai H, Carillo D et al. Computed tomography-based flap brachytherapy for non-melanoma skin cancers of the face. J Contemp Brachytherapy 2021; 13: 51-58.
  36. Scherf C, Licher J, Mletzko C et al. Individualized mould-based high-dose-rate brachytherapy for perinasal skin tumors: technique evaluation from a dosimetric point of view. J Contemp Brachytherapy 2021; 13: 179-187.
  37. Granero D, Perez-Calatayud J, Vijande J et al. Limitations of the TG-43 formalism for skin high-dose-rate brachytherapy dose calculations. Med Phys 2014; 41: 021703.
  38. Howie A, Poder J, Brown R et al. Comparison of TG43 and Hounsfield Unit-based TG186 brachytherapy dose metrics in Oncentra Brachy for 100 patients receiving interstitial partial breast irradiation. Brachytherapy 2021; 20: 655-663.
  39. Rosa E, Fionda B, Vaccaro M et al. Dosimetric impact of air gaps in high-dose-rate contact interventional radiotherapy (modern brachytherapy) for non-melanoma skin cancer of the ear. J Clin Med 2025; 14: 7790.
  40. Kuncman Ł, Kozłowski S, Pietraszek A et al. Highly conformal CT based surface mould brachytherapy for non-melanoma skin cancers of earlobe and nose. J Contemp Brachytherapy 2016; 8: 195-200.
  41. Parsai E, Horne S, Shvydka D et al. Dosimetric analysis of irregular surfaces treated with the Leipzig and Valencia HDR skin applicators. Int J Radiat Oncol Biol Phys 2013; 87: S693.
  42. Tegaw EM, Gholami S, Omyan G et al. Dosimetric characteristics of the INTRABEAM® system with spherical applicators in the presence of air gaps and tissue heterogeneities. Radiat Environ Biophys 2020; 59: 295-306.
  43. Poltorak M, Banatkiewicz P, Poltorak L et al. Reproducibility and air gap pockets of 3D-printed brachytherapy applicator placement in high-dose-rate skin cancer. Phys Med 2024; 123: 103401.
  44. Wang X, Wang X, Xiang Z et al. The clinical application of 3D-printed boluses in superficial tumor radiotherapy. Front Oncol 2021; 11: 698773.
  45. Nath R, Anderson LL, Luxton G et al. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. Med Phys 1995; 22: 209-234.
  46. Beaulieu L, Tedgren AC, Carrier JF et al. Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: Current status and recommendations for clinical implementation. Med Phys 2012; 39: 6208-6236.
  47. Famulari G, Renaud MA, Poole CM et al. RapidBrachyMCTPS: a Monte Carlo-based treatment planning system for brachytherapy applications. Phys Med Biol 2018; 63: 175007.
  48. Enger SA, Vijande J, Rivard MJ. Model-based dose calculation algorithms for brachytherapy dosimetry. Semin Radiat Oncol 2020; 30: 77-86.
  49. Rosa E, Raponi S, Fionda B et al. 3D-printed devices in interventional radiotherapy (brachytherapy) applications: a literature review. J Pers Med 2025; 15: 262.
  50. Rosa E, Raponi S, Fionda B et al. Intensity-modulated interventional radiotherapy (modern brachytherapy) using 3D-printed applicators with multilayer geometry and high-density shielding materials for the NMSC treatment. J Pers Med 2025; 15: 460.
  51. Papait A, Perini G, Palmieri V et al. Defining the immunological compatibility of graphene oxide-loaded PLGA scaffolds for biomedical applications. Biomater Adv 2024; 165: 214024.
  52. Poltorak M, Banatkiewicz P, Poltorak L et al. Brachytherapy and 3D printing for skin cancer: A review paper. J Contemp Brachytherapy 2024; 16: 156-169.
  53. Jones EL, Tonino Baldion A, Thomas et al. Introduction of novel 3D-printed superficial applicators for high-dose-rate skin brachytherapy. Brachytherapy 2017; 16: 409-414.
  54. Bielęda G, Chicheł A, Boehlke M et al. 3D printing of individual skin brachytherapy applicator: design, manufacturing, and early clinical results. J Contemp Brachytherapy 2022; 14: 205-214.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Indexed in
pubmed
Integrated with
integrated with publons
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications